-
NYU Dataset
Cerebral Microbleeds and Leukoencephalopathy in Critically Ill Patients With COVID-19
- Authors
- Shashank AgarwalRajan JainSiddhant DograPenina Krieger4 more author(s)...
- Description
This dataset contains information from 115 patients who were hospitalized at NYU Langone Health facilities between March 1, 2020 and May 10, 2020 and met the following inclusion criteria: had a positive SARS-CoV-2 (COVID-19) test, underwent cerebral magnetic resonance imaging (MRI), and were at least 18 years old. These patients were further assessed for leukoencephalopathy and cerebral microbleeds. Data...
- Subject
-
COVID-19Risk Factors
- Timeframe
- 2020
- Access Rights
- Free to All
-
NYU Dataset
Anti-DNA and Anti-Phosphatidylserine Antibodies Predicted Development of Severe COVID-19
- Authors
- Claudia GomesMarisol ZunigaKelly A. CrottyKun Qian11 more author(s)...
- Description
This is a retrospective cohort study of COVID-19 hospitalized patients with different degrees of severity. They performed this study to analyze the generation of autoimmune antibodies to common antigens. This study included 115 hospitalized patients with SARS-CoV-2 infection and 42 uninfected controls. Sample collection was performed as part of routine clinical care for COVID-19 patients at the time...
- Subject
-
COVID-19Infectious Disease
- Timeframe
- 2020
- Access Rights
- Free to All
-
NYU Dataset
Autoimmunity to Annexin A2 Predicts Mortality Among Hospitalised COVID-19 Patients
- Authors
- Marisol ZunigaClaudia GomesSteven E. CarsonsMichael T. Bender4 more author(s)...
- Description
This study examined autoimmune antibodies to annexin A2, which is a phospholipid-binding protein expressed in the lung and other organs, in COVID-19 patients. Annexin A2 is critical for fibrinolysis, lung elasticity, cell membrane repair, and integrity of the pulmonary vasculature. Therefore, antagonism of annexin A2 may explain many of the clinical features of severe COVID-19 cases. This study analyzed...
- Subject
-
COVID-19Infectious Disease
- Access Rights
- Application RequiredAuthor Approval Required